Literature DB >> 6766950

Inhibition of Pseudomonas aeruginosa slime production by staphylococcal extracellular product.

A M Shibl, I A Al-Sowaygh.   

Abstract

Staphylococcus aureus produced an inhibitory factor that suppressed slime formation by Psuudomonas aeruginosa but had little effect on the growth of the organism. The inhibitory factor was not found in broth cultures but could be extracted from cultures grown on solid agar. The inhibitory factor moderately inhibited gram-negative bacteria in addition to inhibiting a variety of gram-positive bacteria. The inhibitory factor was found to have a low molecular weight, as judged by its diffusibility, and it could be partially purified by gel filtration on Sephadex G-50. It was observed to be heat labile; however, its activity was stable within a wide pH range. The factor was resistant to deoxyribonuclease, ribonuclease, and lipase, but sensitive to trypsin. The role of the inhibition of slime production in pathogenicity is discussed.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6766950      PMCID: PMC273336          DOI: 10.1128/jcm.11.2.123-126.1980

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  9 in total

Review 1.  THE BACTERIOCINS.

Authors:  P REEVES
Journal:  Bacteriol Rev       Date:  1965-03

2.  Exopolysaccharide production by Pseudomonas NCIB11264 grown in batch culture.

Authors:  A G Williams; J W Wimpenny
Journal:  J Gen Microbiol       Date:  1977-09

Review 3.  Bacterial exopolysaccharides.

Authors:  I W Sutherland
Journal:  Adv Microb Physiol       Date:  1972       Impact factor: 3.517

4.  Opportunistic infection.

Authors:  H Smith
Journal:  Br Med J       Date:  1973-04-14

5.  Characterization of a Staphylococcus aureus bacteriocin.

Authors:  V J Gagliano; R D Hinsdill
Journal:  J Bacteriol       Date:  1970-10       Impact factor: 3.490

6.  Infection in cystic fibrosis.

Authors:  J P Kilbourn
Journal:  Lancet       Date:  1970-10-24       Impact factor: 79.321

7.  Mucoid Pseudomonas aeruginosa in patients with chronic illnesses.

Authors:  R G Doggett; G M Harrison; R E Carter
Journal:  Lancet       Date:  1971-01-30       Impact factor: 79.321

8.  Characteristics of a bacteriocin derived from Streptococcus faecalis var. zymogenes antagonistic to Diplococcus peumoniae.

Authors:  E Bottone; J Allerhand; M A Pisano
Journal:  Appl Microbiol       Date:  1971-08

9.  [Increase of resistance to Pseudomonas aeruginosa infection in mice caused by Staphylococcus aureus].

Authors:  J deRepentigny; L G Mathieu; J Coallier-Ascah
Journal:  Can J Microbiol       Date:  1976-07       Impact factor: 2.419

  9 in total
  1 in total

1.  Isolation and characterization of an alginase from mucoid strains of Pseudomonas aeruginosa.

Authors:  A Linker; L R Evans
Journal:  J Bacteriol       Date:  1984-09       Impact factor: 3.490

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.